SYRA HEALTH CORP. Other Noncash Expense
SYRA HEALTH CORP. (SYRA) reported Other Noncash Expense of $89.50 thousand for the 12-month period ending 2024-12-31, per its S-1 filed 2026-09-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashExpense · last filed 2026-09-14
- SYRA HEALTH CORP. other noncash expense for the quarter ending 2024-12-31 was $26.30K.
- SYRA HEALTH CORP. other noncash expense for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- SYRA HEALTH CORP. other noncash expense for the quarter ending 2024-06-30 was $31.83K, a 5.90% increase year-over-year.
- SYRA HEALTH CORP. other noncash expense for the quarter ending 2024-03-31 was $31.37K, a 5.90% increase year-over-year.
- SYRA HEALTH CORP. other noncash expense for fiscal 2022 was $95.56K.
| Period end | Other Noncash Expense 3 month | Other Noncash Expense 6 month | Other Noncash Expense 9 month | Other Noncash Expense 12 month |
|---|---|---|---|---|
| 2024-12-31 | $26.30K derived: S-1 12 month − 10-Q 9 month · filed 2026-09-14 | $26.30K derived: sum of 2 quarters · filed 2026-09-14 | $58.13K derived: sum of 3 quarters · filed 2026-09-14 | $89.50K S-1 · filed 2026-09-14 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $31.83K derived: sum of 2 quarters · filed 2025-11-12 | $63.20K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $31.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $63.20K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $31.37K 10-Q · filed 2025-05-08 | |||
| 2023-09-30 | $30.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $60.54K derived: sum of 2 quarters · filed 2024-10-29 | $90.16K 10-Q · filed 2024-10-29 | $119.36K derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | $30.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $59.68K 10-Q · filed 2024-08-08 | $88.88K derived: sum of 3 quarters · filed 2024-08-08 | |
| 2023-03-31 | $29.62K 10-Q · filed 2024-05-09 | $58.83K derived: sum of 2 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $29.20K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $95.56K 10-K · filed 2024-03-25 | ||
| 2022-09-30 | $66.36K 10-Q · filed 2023-11-14 |